7-117548746-C-T

Variant summary

Our verdict is Likely pathogenic. Variant got 7 ACMG points: 7P and 0B. PM1PM2PP3_ModeratePP5

The NM_000492.4(CFTR):​c.1315C>T​(p.Pro439Ser) variant causes a missense change. The variant allele was found at a frequency of 0.00000248 in 1,612,790 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0000066 ( 0 hom., cov: 33)
Exomes 𝑓: 0.0000021 ( 0 hom. )

Consequence

CFTR
NM_000492.4 missense

Scores

7
8
4

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:7U:1

Conservation

PhyloP100: 5.48
Variant links:
Genes affected
CFTR (HGNC:1884): (CF transmembrane conductance regulator) This gene encodes a member of the ATP-binding cassette (ABC) transporter superfamily. The encoded protein functions as a chloride channel, making it unique among members of this protein family, and controls ion and water secretion and absorption in epithelial tissues. Channel activation is mediated by cycles of regulatory domain phosphorylation, ATP-binding by the nucleotide-binding domains, and ATP hydrolysis. Mutations in this gene cause cystic fibrosis, the most common lethal genetic disorder in populations of Northern European descent. The most frequently occurring mutation in cystic fibrosis, DeltaF508, results in impaired folding and trafficking of the encoded protein. Multiple pseudogenes have been identified in the human genome. [provided by RefSeq, Aug 2017]
CFTR-AS1 (HGNC:40144): (CFTR antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_pathogenic. Variant got 7 ACMG points.

PM1
In a domain ABC transporter 1 (size 223) in uniprot entity CFTR_HUMAN there are 54 pathogenic changes around while only 9 benign (86%) in NM_000492.4
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.932
PP5
Variant 7-117548746-C-T is Pathogenic according to our data. Variant chr7-117548746-C-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 53226.We mark this variant Likely_pathogenic, oryginal submissions are: {Likely_pathogenic=6, Uncertain_significance=1, Pathogenic=1}.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CFTRNM_000492.4 linkc.1315C>T p.Pro439Ser missense_variant Exon 10 of 27 ENST00000003084.11 NP_000483.3 P13569-1A0A024R730
CFTR-AS1NR_149084.1 linkn.222-6207G>A intron_variant Intron 2 of 2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CFTRENST00000003084.11 linkc.1315C>T p.Pro439Ser missense_variant Exon 10 of 27 1 NM_000492.4 ENSP00000003084.6 P13569-1

Frequencies

GnomAD3 genomes
AF:
0.00000657
AC:
1
AN:
152148
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD4 exome
AF:
0.00000205
AC:
3
AN:
1460642
Hom.:
0
Cov.:
36
AF XY:
0.00000275
AC XY:
2
AN XY:
726598
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00000180
Gnomad4 OTH exome
AF:
0.0000166
GnomAD4 genome
AF:
0.00000657
AC:
1
AN:
152148
Hom.:
0
Cov.:
33
AF XY:
0.00
AC XY:
0
AN XY:
74310
show subpopulations
Gnomad4 AFR
AF:
0.0000241
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.0000282
Hom.:
0

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:7Uncertain:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Cystic fibrosis Pathogenic:4Uncertain:1
Aug 20, 2024
Ambry Genetics
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

The p.P439S variant (also known as c.1315C>T), located in coding exon 10 of the CFTR gene, results from a C to T substitution at nucleotide position 1315. The proline at codon 439 is replaced by serine, an amino acid with similar properties. This variant was reported in a 10-year-old male with a sweat chloride level of 59 mmol/L, pancreatic insufficiency, and recurrent Staphylococcus infections (Schrijver I et al. J Mol Diagn, 2005 May;7:289-99). In a patient with congenital bilateral absence of the vas deferens, this variant was detected in conjunction with a pathogenic allele (Grangeia A et al. Genet. Med., 2007 Mar;9:163-72). In vitro functional analyses showed this alteration resulted in a reduction of mature CFTR protein and chloride channel activity (Grangeia A et al. Cell. Physiol. Biochem., 2008 Jul;22:79-92). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -

Feb 05, 2022
DASA
Significance: Likely pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

The c.1315C>T;p.(Pro439Ser) missense variant has been observed in affected individual(s) and ClinVar contains an entry for this variant (ClinVar ID: 53226; PMID: 15858154; 17413420) - PS4_moderate. Well-established in vitro or in vivo functional studies supportive of a damaging effect on the gene or gene product (PMID: 18769034) - PS3_supporting. The variant is present at low allele frequencies population databases (rs397508187 – gnomAD 0.00006573%; ABraOM 0.000854 frequency - http://abraom.ib.usp.br/) - PM2_supporting. The p.(Pro439Ser) was detected in trans with a pathogenic variant (PMID: 15858154; 17413420) - PM3. Multiple lines of computational evidence support a deleterious effect on the gene or gene product - PP3. In summary, the currently available evidence indicates that the variant is likely pathogenic. -

Aug 19, 2024
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance: Likely pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

Variant summary: CFTR c.1315C>T (p.Pro439Ser) results in a non-conservative amino acid change located in the ABC transporter-like domain (IPR003439) of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant was absent in 242792 control chromosomes. c.1315C>T has been reported in the literature in compound heterozygosity with p.R668C in one comprehensively genotyped patient with mild CF (Schrijver_2005), in compound heterozygosity with p.R334W in one patient with CBAVD (Grangeia_2007), in compound heterozygosity with p.F508del in one comprehensively genotyped patient with azoospermia (Ooi_2014). Each of these patients is ascertained in the context of the broad phenotypic spectrum of CF and related disorders. These data indicate that the variant may be associated with disease. At least one publications reports experimental evidence evaluating an impact on protein function. The most pronounced variant effect resulted in approximately 20% of normal chloride channel conductance relative to wild type (e.g., Bihler_2024). The following publications have been ascertained in the context of this evaluation (PMID: 15858154, 17413420, 25735457, 24697796, 29216686, 18769034, 38388235). ClinVar contains an entry for this variant (Variation ID: 53226). Based on the evidence outlined above, the variant was classified as likely pathogenic. -

Jul 22, 2021
Genome-Nilou Lab
Significance: Likely pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Nov 27, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This sequence change replaces proline, which is neutral and non-polar, with serine, which is neutral and polar, at codon 439 of the CFTR protein (p.Pro439Ser). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with mild / atypical cystic fibrosis, congenital absence of the vas deferens, or obstructive azoospermia (PMID: 15858154, 17413420, 24697796). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 53226). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt CFTR protein function with a positive predictive value of 80%. Experimental studies have shown that this missense change affects CFTR function (PMID: 18769034). For these reasons, this variant has been classified as Pathogenic. -

not provided Pathogenic:2
Mar 22, 2023
Mayo Clinic Laboratories, Mayo Clinic
Significance: Likely pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

PP3, PM2, PM3, PS4_moderate -

Aug 09, 2023
Quest Diagnostics Nichols Institute San Juan Capistrano
Significance: Likely pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

The CFTR c.1315C>T (p.Pro439Ser) variant has been reported in the published literature in along with another CFTR variant in an individual with cystic fibrosis (PMID: 15858154 (2005)). This variant has been reported along with other CFTR variants in individuals with CFTR related disorders including azoospermia (PMID: 24697796 (2014)), congenital bilateral absence of the vas deferens (CBAVD)(PMID: 17413420 (2007)) and pancreatitis (CFTR-France (https://cftr.iurc.montp.inserm.fr/)). Published functional studies showed that this variant results in reduced levels of mature CFTR protein and defective trafficking to the cell membrane (PMID: 18769034 (2008)). This variant has not been reported in large, multi-ethnic general populations (Genome Aggregation Database, http://gnomad.broadinstitute.org). Based on the available information, this variant is classified as likely pathogenic. -

Bronchiectasis with or without elevated sweat chloride 1 Pathogenic:1
Jan 18, 2024
Baylor Genetics
Significance: Likely pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.20
BayesDel_addAF
Pathogenic
0.38
D
BayesDel_noAF
Pathogenic
0.31
CADD
Uncertain
25
DANN
Pathogenic
1.0
DEOGEN2
Pathogenic
0.85
D;T
Eigen
Uncertain
0.63
Eigen_PC
Uncertain
0.62
FATHMM_MKL
Uncertain
0.97
D
LIST_S2
Uncertain
0.97
D;D
M_CAP
Pathogenic
0.45
D
MetaRNN
Pathogenic
0.93
D;D
MetaSVM
Uncertain
0.69
D
MutationAssessor
Benign
1.8
L;.
PrimateAI
Benign
0.46
T
PROVEAN
Uncertain
-3.3
D;D
REVEL
Pathogenic
0.85
Sift
Uncertain
0.015
D;D
Sift4G
Uncertain
0.0070
D;D
Polyphen
1.0
D;.
Vest4
0.82
MutPred
0.81
Gain of sheet (P = 0.0827);.;
MVP
0.99
MPC
0.0045
ClinPred
0.98
D
GERP RS
4.8
Varity_R
0.67
gMVP
0.84

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs397508187; hg19: chr7-117188800; API